"" Australia's third vaccine option, Novavax, has been contracted for 51 million doses but is unlikely to be approved for use in Australia for several months as it is still undergoing phase three clinical trials in the United Kingdom."
- Forums
- ASX - By Stock
- IDT
- Ann: COVID19 Vaccine Feasibility Assessment
Ann: COVID19 Vaccine Feasibility Assessment, page-580
-
- There are more pages in this discussion • 351 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IDT (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.40M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.5¢ | $7.845K | 66.43K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 173739 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 56838 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 173739 | 0.115 |
8 | 433265 | 0.110 |
5 | 600238 | 0.105 |
3 | 176666 | 0.100 |
1 | 30000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 40000 | 1 |
0.130 | 131481 | 3 |
0.135 | 498000 | 3 |
0.140 | 242737 | 5 |
0.145 | 152627 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
IDT (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online